Mesenchymal stem cell (MSC)-based therapy has been considered as a promising
approach targeting a variety of intractable diseases due to remarkable multiple effect of …

Mesenchymal stem cells (MSCs) have been widely studied as a versatile cell source for
tissue regeneration and remodeling due to their potent bioactivity, which includes …

Mesenchymal stem cells (MSCs) are the most frequently used stem cells in clinical trials due
to their easy isolation from various adult tissues, their ability of homing to injury sites and …

Cell-based therapies have the potential to revolutionize current treatments for diseases with
high prevalence and related economic and social burden. Unfortunately, clinical trials have …

Cellular therapy aims to replace damaged resident cells by restoring cellular and molecular
environments suitable for tissue repair and regeneration. Among several candidates …

Hypoxia‐mimetic agents are new potential tools in MSC priming instead of hypoxia
incubators or chambers. Several pharmaceutical/chemical hypoxia‐mimetic agents can be …

Mesenchymal stem cells (MSCs) are promising candidates for bone regeneration therapies
due to their plasticity and easiness of sourcing. MSC-based treatments are generally …

Recent studies have demonstrated that culture under hypoxia has beneficial effects on
mesenchymal stem cells (MSCs). However, there are limitations to achieving a stable …

Background Adipose tissue-derived mesenchymal stromal cells (ASCs) have been shown to
exhibit some promising properties of their use in regenerative medicine as advanced …

Ischemic diseases are conditions associated with the restriction or blockage of blood supply
to specific tissues. These conditions can cause moderate to severe complications in …